Detalhe da pesquisa
1.
Immunogenicity of Cemiplimab: Low Incidence of Antidrug Antibodies and Cut-Point Suitability Across Tumor Types.
J Clin Pharmacol
; 64(1): 125-136, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37656820
2.
Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays.
AAPS J
; 23(6): 109, 2021 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34608545
3.
A constitutive, transient receptor potential-like Ca2+ influx pathway in presynaptic nerve endings independent of voltage-gated Ca2+ channels and Na+/Ca2+ exchange.
J Biol Chem
; 282(49): 36102-11, 2007 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-17928293